mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.0003 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0005 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.0009 |